SurpassMD review

SurpassMD for mothers: our verdict

Both prices on this site are promotional, and SurpassMD says so itself — buried in the FAQ rather than beside the numbers: "Semaglutide starts as low as $114/m and tirzepatide starts as low as $177/m for eligible patients with a promotion." What it never publishes is the price without one. The rest is unusually well covered: all fifty states plus DC, a 503A pharmacy, cold-chain shipping inside 48 hours, cancel anytime, and an oral semaglutide option — priced nowhere. It runs about $114/month — toward the affordable end of what we track.

We weigh SurpassMD the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.

What SurpassMD costs, in full

• Compounded semaglutide — Promotional starting price: $114/mo
• Compounded tirzepatide — Promotional starting price: $177/mo

That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.

SurpassMD says the price covers the medication and shipping. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.

The medications SurpassMD prescribes

SurpassMD prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.

A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.

Where SurpassMD fits — and where it doesn't — for mothers

A good fit if…

• the monthly cost is a real barrier and you want a low, predictable number.
• switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
• uninterrupted nationwide access matters — a move for family shouldn't interrupt care.

Look elsewhere if…

• you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
• you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.

Oversight, safety, and what we could verify

Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.

A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.

The bottom line

SurpassMD is a genuine value play — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.